首页>
外国专利>
How to taxane-based anticancer agents, platinum complex-based anti-cancer agent, and sorting the effective group of cancer treatment was a combination of three types of fluoropyrimidine anti-cancer agent
How to taxane-based anticancer agents, platinum complex-based anti-cancer agent, and sorting the effective group of cancer treatment was a combination of three types of fluoropyrimidine anti-cancer agent
How to taxane-based anticancer agents, platinum complex-based anti-cancer agent, and sorting the effective group of cancer treatment was a combination of three types of fluoropyrimidine anti-cancer agents, as well as the present invention is that the taxane-based anti- was intended that do agent, a platinum-based complex anticancer agent, and to provide a reagent for predicting the effects of cancer therapy in combination the three fluoropyrimidine anticancer agent. PDGFB gene, PCGF3 gene, CISH gene, ANXA5 gene, ANTXR2 gene, B4GALT5 gene, PLK2 gene, ATP7B gene, FAM116A gene, HECA gene, JMJD2A gene, STYX gene, EGR1 gene, AVPI1 gene, and selected from the group consisting of ERLIN1 gene as an indicator the amount of expression product of one gene, taxane-based anticancer agents, platinum complex-based anti-cancer agents, and treatment of cancer in combination the three fluoropyrimidine anti-cancer agent is at least How to select the effective group.
展开▼